Enhanced tracer [F-18]-fluorodeoxyglucose (FDG) uptake, quantified by PET, has been shown to relate to increased GLUT1 expression in ovarian cancer and was related to increased cellular proliferation [59]. The gene discussed is SLC2A1; the disease is ovarian carcinoma.